Eiger BioPharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is …

Biotechnology
US, Palo Alto [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of EIGR's Analysis
CIK: 1305253 CUSIP: 28249U105 ISIN: US28249U2042 LEI: - UEI: -
Secondary Listings
EIGR has no secondary listings inside our databases.